Ben Lenail, healthtech C

Ben Lenail

 Ben Lenail is a founding officer of ALD Connect, a research consortium focused on a rare neuro-metabolic disease. Ben serves on the Advisory Board of Stanford Medicine and of the UCSF Center for Vulnerable Populations.


Ben was director of business development at Alta Devices, a solar energy company in Sunnyvale. He was previously a distinguished visiting scholar at Stanford University, and Senior Director of Corporate Development at Sun Microsystems. Ben has a Bachelor’s from Sciences Po (Paris, France) and an MBA from the University of Washington.

 

In his free time, Ben enjoys tutoring kids and mentoring young professionals, and cycling & walking with his beloved Golden Retriever Hazel.


LinkedIn